Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Current Leases (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Current Leases data on record, last reported at $1.6 million in Q4 2025.

  • For Q4 2025, Current Leases rose 15.87% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, up 15.87%, while the annual FY2025 figure was $1.6 million, 15.87% up from the prior year.
  • Current Leases reached $1.6 million in Q4 2025 per PLSE's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.6 million in Q4 2025 and bottomed at $629000.0 in Q1 2021.
  • Average Current Leases over 5 years is $1.1 million, with a median of $1.1 million recorded in 2021.
  • Peak YoY movement for Current Leases: soared 95.2% in 2021, then fell 15.31% in 2022.
  • A 5-year view of Current Leases shows it stood at $1.1 million in 2021, then dropped by 15.31% to $896000.0 in 2022, then increased by 18.08% to $1.1 million in 2023, then grew by 28.07% to $1.4 million in 2024, then rose by 15.87% to $1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $1.6 million in Q4 2025, $1.5 million in Q3 2025, and $1.5 million in Q2 2025.